Domain structure of the carboxyl-terminal half of human plasma fibronectin.
about
Stuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive BacteriaRegulation of fibronectin receptor distributionStaphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein.Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.Fibronectin: functional character and role in alcoholic liver disease.Matrix-driven translocation: dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles.Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix.The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesionInteraction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts.Location of a fibronectin domain involved in newt epidermal cell migration.Collagen can modulate cell interactions with fibronectinHuman fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cellsCharacterization of a 140-kD avian cell surface antigen as a fibronectin-binding molecule.Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectinNeurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segmentModulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domainSpecific binding of the human monocytic cell line U937 to the alternatively spliced connecting segment (IIICS) of fibronectinFibronectin tetrapeptide is target for syphilis spirochete cytadherence.Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin functionMonoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly.The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clotsOn the origin of species of fibronectin.Incorporation of cellular and plasma fibronectins into smooth muscle cell extracellular matrix in vitro.Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.Fibronectin glycosylation modulates fibroblast adhesion and spreading.Binding to human extracellular matrix by Neisseria meningitidis.Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.The fibronectin cell attachment sequence Arg-Gly-Asp-Ser promotes focal contact formation during early fibroblast attachment and spreadingAdhesion of human T-lymphoid cells to fibronectin is mediated by two different fibronectin domains.Binding properties and adhesion-mediating regions of the major sheath protein of Treponema denticola ATCC 35405.The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.Unfolding transitions of fibronectin and its domains. Stabilization and structural alteration of the N-terminal domain by heparinRegulation of interleukin 1 signalling through integrin binding and actin reorganization: disparate effects on NF-kappaB and stress kinase pathways.Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneityStructural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).Cultured human monocytes secrete fibronectin in response to activation by proinflammatory cytokines.
P2860
Q28067173-5DBD87BA-CF80-4C94-9A29-28CD3C317F59Q28186395-74302B40-8B85-4C9F-AB34-801A1428875FQ32064431-8779DBF4-86B8-46D1-AF4A-83FEABD77E5DQ34617970-074A7CA5-940A-4F00-B0D7-A62C1A32E856Q34629775-D4A82AF7-62EC-4BFC-9EF2-D6A9D3892568Q34638235-EE24E77E-49C7-4507-81D3-6CD75394816FQ34668282-C51BF892-C205-4DDD-94D8-BB57CB47159EQ34684295-9B854B36-F324-45B2-A128-A536A31A78A4Q34684539-F1017B4B-F37E-474E-8955-8CE9EC3BDB7DQ36211533-A19E8808-94D8-4F82-B489-93F74E0890DFQ36212372-944EB839-0541-4193-8991-362EA4E318F7Q36212568-106227C7-6A53-4115-941A-658DBE00BAFEQ36214241-F49456BD-E90A-4F89-AEFC-7730F7FF84BEQ36214439-E26AEA03-1549-49CA-99BE-255D46853EC8Q36217638-96082FDA-CC13-4F6F-9306-B8D37D15A004Q36218423-98D0A4DD-FD22-4449-BB62-A859207E9D2EQ36273978-A5CC1111-8D18-42EC-91C5-7531B0C92317Q36349900-40B77C5A-2CE3-4333-AA82-9ACB20EDB7BEQ36350241-FCDC184E-BF6A-41FC-9D9E-6FC2946A196CQ36351157-01056A40-AB11-4997-858C-E66E69939CE5Q36510361-C8CB06B4-8A28-43E3-87CA-CA28620F53F2Q36530275-5975144B-6DCF-40E3-9669-0478AE086356Q36532196-A35D9B4F-97B1-4460-9F9F-A2E31930F9BAQ37679348-2DF724F9-C015-46C1-A97F-ACFFB9472D59Q37685831-3711E093-2812-453A-9CE0-E8098B9F9299Q38328031-CD22CB48-CA82-4321-BB52-CF5C5E22C1B9Q38348430-63811DEC-8020-4125-B8B0-86FBAECA679AQ38350317-ACC52C72-4080-43BE-BFB8-B29184411FFAQ39570875-8C573C46-8270-4AFB-A49B-1A18F72C7E20Q40161756-294B6209-98E1-4F92-9276-78CA59767BC2Q41519751-B04B577F-58BB-454C-8FDF-5BE00EC70C3EQ41754131-54DEFB1E-6F76-4F6B-9556-4AB8E539785CQ41820683-32537A5E-06C4-4D13-8D5B-4ABD706077A5Q41838466-C5B0A6EF-2C55-40CA-8828-94863C9E1479Q41878832-EF179C91-4CD7-45E4-83D8-F9AAD2164E6BQ41881846-E02E1736-9434-461B-ACDE-94A35987EBFEQ42134618-C97A4767-A23A-4E71-AA34-857ECFEB42F9Q42160055-B2276889-984B-4CAF-AFD8-35B85A0CFD17Q53840787-FA05446A-A552-4124-A3F5-973EFA0B4A5F
P2860
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
description
1983 nî lūn-bûn
@nan
1983 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մարտին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@ast
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@en
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@nl
type
label
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@ast
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@en
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@nl
prefLabel
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@ast
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@en
Domain structure of the carboxyl-terminal half of human plasma fibronectin.
@nl
P1476
Domain structure of the carboxyl-terminal half of human plasma fibronectin
@en
P2093
P304
P407
P577
1983-03-01T00:00:00Z